248 related articles for article (PubMed ID: 35413989)
1. Increased expression of TIGIT and KLRG1 correlates with impaired CD56
Nie Y; Liu D; Yang W; Li Y; Zhang L; Cheng X; Chen R; Yuan B; Zhang G; Wang H
Virol J; 2022 Apr; 19(1):68. PubMed ID: 35413989
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
Yang W; Song Y; Lu YL; Sun JZ; Wang HW
Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696
[TBL] [Abstract][Full Text] [Related]
3. The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56
Ziegler AE; Fittje P; Müller LM; Ahrenstorf AE; Hagemann K; Hagen SH; Hess LU; Niehrs A; Poch T; Ravichandran G; Löbl SM; Padoan B; Brias S; Hennesen J; Richard M; Richert L; Peine S; Oldhafer KJ; Fischer L; Schramm C; Martrus G; Bunders MJ; Altfeld M; Lunemann S
Front Immunol; 2023; 14():1117320. PubMed ID: 36845105
[TBL] [Abstract][Full Text] [Related]
4. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.
Garcia-Iglesias T; Del Toro-Arreola A; Albarran-Somoza B; Del Toro-Arreola S; Sanchez-Hernandez PE; Ramirez-Dueñas MG; Balderas-Peña LM; Bravo-Cuellar A; Ortiz-Lazareno PC; Daneri-Navarro A
BMC Cancer; 2009 Jun; 9():186. PubMed ID: 19531227
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis.
Solorzano-Ibarra F; Alejandre-Gonzalez AG; Ortiz-Lazareno PC; Bastidas-Ramirez BE; Zepeda-Moreno A; Tellez-Bañuelos MC; Banu N; Carrillo-Garibaldi OJ; Chavira-Alvarado A; Bueno-Topete MR; Del Toro-Arreola S; Haramati J
Clin Exp Immunol; 2021 Apr; 204(1):78-95. PubMed ID: 33306195
[TBL] [Abstract][Full Text] [Related]
6. Involvement of TIGIT in Natural Killer Cell Exhaustion and Immune Escape in Patients and Mouse Model With Liver Echinococcus multilocularis Infection.
Zhang C; Wang H; Li J; Hou X; Li L; Wang W; Shi Y; Li D; Li L; Zhao Z; Li L; Aji T; Lin R; Shao Y; Vuitton DA; Tian Z; Sun H; Wen H
Hepatology; 2021 Dec; 74(6):3376-3393. PubMed ID: 34192365
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
[TBL] [Abstract][Full Text] [Related]
8. [Effect of hnRNP K and its interaction with HPV16 on cervical intraepithelial neoplasia].
Ding L; Feng MJ; Liu CL; Wang L; Song ZC; Yang Q; Li XX; Song L; Gao W; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1630-1635. PubMed ID: 30572391
[No Abstract] [Full Text] [Related]
9. Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status.
Yang W; Lu YP; Yang YZ; Kang JR; Jin YD; Wang HW
J Obstet Gynaecol Res; 2017 Oct; 43(10):1602-1612. PubMed ID: 28833798
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.
Hu T; Yang P; Zhu H; Chen X; Xie X; Yang M; Liu S; Wang H
Diagn Pathol; 2015 Apr; 10():20. PubMed ID: 25885042
[TBL] [Abstract][Full Text] [Related]
11. The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.
Li W; Wang W; Si M; Han L; Gao Q; Luo A; Li Y; Lu Y; Wang S; Ma D
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1355-61. PubMed ID: 18478264
[TBL] [Abstract][Full Text] [Related]
12. KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection.
Wang JM; Cheng YQ; Shi L; Ying RS; Wu XY; Li GY; Moorman JP; Yao ZQ
J Virol; 2013 Nov; 87(21):11626-36. PubMed ID: 23966413
[TBL] [Abstract][Full Text] [Related]
13. Cell mediated immunity against HPV16 E2, E6 and E7 peptides in women with incident CIN and in constantly HPV-negative women followed-up for 10-years.
Paaso A; Koskimaa HM; Welters MJ; Grénman S; Syrjänen K; van der Burg SH; Syrjänen S
J Transl Med; 2015 May; 13():163. PubMed ID: 25990808
[TBL] [Abstract][Full Text] [Related]
14. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
[TBL] [Abstract][Full Text] [Related]
15. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
[TBL] [Abstract][Full Text] [Related]
16. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.
Tjalma WA; Fiander A; Reich O; Powell N; Nowakowski AM; Kirschner B; Koiss R; O'Leary J; Joura EA; Rosenlund M; Colau B; Schledermann D; Kukk K; Damaskou V; Repanti M; Vladareanu R; Kolomiets L; Savicheva A; Shipitsyna E; Ordi J; Molijn A; Quint W; Raillard A; Rosillon D; De Souza SC; Jenkins D; Holl K;
Int J Cancer; 2013 Feb; 132(4):854-67. PubMed ID: 22752992
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease outcome in cervical cancer.
Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Syrjänen S; Favalli C; Syrjänen K;
Eur J Gynaecol Oncol; 2006; 27(3):215-23. PubMed ID: 16800245
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological implications of human papilloma virus (HPV) L1 capsid protein immunoreactivity in HPV16-positive cervical cytology.
Lee SJ; Lee AW; Kang CS; Park JS; Park DC; Ki EY; Lee KH; Yoon JH; Hur SY; Kim TJ
Int J Med Sci; 2014; 11(1):80-6. PubMed ID: 24396289
[TBL] [Abstract][Full Text] [Related]
20. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]